Cargando…
BioSAXS–an emerging method to accelerate, enrich and de-risk antimicrobial drug development
Antimicrobial resistance is a worldwide threat to modern health care. Low-profit margin and high risk of cross-resistance resulted in a loss of interest in big pharma, contributing to the increasing threat. Strategies to address the problem are starting to emerge. Novel antimicrobial compounds with...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445215/ https://www.ncbi.nlm.nih.gov/pubmed/36081947 http://dx.doi.org/10.3389/fphar.2022.947005 |